Pediatric Emergencies — Part 2: Pediatric Respiratory Emergencies

Croup scoring and management, bronchiolitis evaluation and supportive care, acute asthma severity classification and stepwise treatment, anaphylaxis recognition and epinephrine dosing, and foreign body aspiration management.

guidelinesMar 2026guidelines

1. Croup (Laryngotracheobronchitis)

Croup is the most common cause of acute upper airway obstruction in children aged 6 months to 6 years, with a peak incidence at 1 to 2 years of age. It is caused by viral infection (most commonly parainfluenza types 1 and 3, but also RSV, influenza, adenovirus, and human metapneumovirus) producing inflammation and edema of the subglottic airway. The hallmark triad of barky (seal-like) cough, inspiratory stridor, and hoarseness is usually preceded by 1-3 days of upper respiratory symptoms. Symptoms characteristically worsen at night.1 2

1.1 Westley Croup Severity Score

The Westley Croup Score is the most widely validated and utilized clinical scoring system for assessing croup severity. Scores range from 0 to 17, with higher scores indicating more severe disease.1

Feature0 Points1 Point2 Points3 Points4 Points5 Points
Chest wall retractionsNoneMildModerateSevere
StridorNoneWith agitationAt rest
Air entryNormalDecreasedMarkedly decreased
CyanosisNoneWith agitationAt rest
Level of consciousnessNormalDisoriented

Severity Classification:

ScoreSeverityClinical Features
0–2MildOccasional barky cough; no stridor at rest; no or mild retractions
3–5ModerateFrequent barky cough; stridor at rest; retractions at rest; no agitation
6–11SevereFrequent barky cough; prominent stridor at rest; marked retractions; agitation or lethargy
12–17Impending respiratory failureDiminished stridor (may indicate critical obstruction); lethargy; markedly decreased air entry; cyanosis

1.2 Croup Management Ladder

SeverityTreatmentDose / Details
Mild (0–2)Dexamethasone (single dose)0.6 mg/kg PO/IM (max 10 mg); PO preferred if tolerated
Supportive careCool mist humidification (unproven but widely used); comfort measures; may discharge if improved after observation
Moderate (3–5)Dexamethasone (single dose)0.6 mg/kg PO/IM (max 10 mg)
Nebulized epinephrineRacemic epinephrine 0.5 mL of 2.25% solution in 3 mL NS via nebulizer, OR L-epinephrine 0.5 mL/kg of 1:1,000 (max 5 mL) via nebulizer
ObservationObserve for minimum 2-4 hours after nebulized epinephrine for rebound (return of symptoms after epinephrine effect wanes at 1-2 hours)
Severe (6–11)Dexamethasone (single dose)0.6 mg/kg PO/IM (max 10 mg); IM if unable to take PO
Nebulized epinephrineSame dose as above; may repeat every 15-20 minutes for up to 3 doses if needed
Supplemental oxygenBlow-by or humidified oxygen as tolerated; avoid agitating the child (agitation worsens obstruction)
AdmissionAdmit if persistent stridor at rest after treatment; multiple epinephrine nebulizations required
Impending failure (12–17)All above interventions
Prepare for advanced airwayCall anesthesia/ENT; prepare for intubation with ETT 0.5-1 mm smaller than age-predicted size
Heliox70:30 or 80:20 helium-oxygen mixture may reduce work of breathing (if available, not requiring >30% FiO2)

1.3 Key Points

  • Dexamethasone 0.6 mg/kg is the single most effective treatment for croup at all severity levels; benefit seen within 2-4 hours and lasts 24-72 hours
  • Lower doses (0.15 mg/kg) have shown comparable efficacy in some studies for mild-moderate croup, but 0.6 mg/kg remains the standard recommended dose
  • Nebulized epinephrine provides rapid temporary relief (onset 10-30 minutes) but does not shorten disease course; observe for rebound
  • Antibiotics are not indicated — croup is virtually always viral
  • Radiographs are not routinely needed — the classic “steeple sign” on AP neck film has poor sensitivity and specificity; obtain imaging only if the diagnosis is uncertain or foreign body is suspected
  • Consider bacterial tracheitis if a child with croup-like symptoms has high fever, toxic appearance, and fails to respond to standard therapy1 2

2. Bronchiolitis

Bronchiolitis is the most common lower respiratory tract infection in infants, typically affecting children younger than 2 years (peak 2-6 months). Respiratory syncytial virus (RSV) is responsible for 50-80% of cases, with other causes including rhinovirus, human metapneumovirus, parainfluenza, influenza, and adenovirus. The clinical guideline emphasizes supportive care, as numerous trials have demonstrated no benefit from bronchodilators, corticosteroids, or antibiotics in typical bronchiolitis.3 4

2.1 Clinical Diagnosis and Assessment

Bronchiolitis is a clinical diagnosis. Key features include:

  • Age typically <2 years (most commonly <12 months)
  • Preceded by 2-4 days of URI symptoms (rhinorrhea, cough, low-grade fever)
  • Progressive cough, tachypnea, wheezing, crackles, increased work of breathing
  • Difficulty feeding due to respiratory distress

Severity Assessment:

SeverityClinical Features
MildSpO2 ≥92%; feeding well (taking >50% usual feeds); mild tachypnea; mild or no retractions; comfortable and alert
ModerateSpO2 90-92%; reduced feeding (taking 50-75% usual feeds); moderate tachypnea; subcostal/intercostal retractions; some agitation
SevereSpO2 <90%; unable to feed or taking <50% usual feeds; marked tachypnea or apnea; severe retractions with nasal flaring and grunting; lethargic or irritable
InterventionDetails
Nasal suctioningGentle bulb or mechanical suction of the nasopharynx to clear secretions; most effective before feeds and before respiratory assessment
Supplemental oxygenIndicated if SpO2 persistently <90%; target SpO2 ≥90% (not 94-98%); avoid continuous pulse oximetry in stable infants as transient desaturations may trigger unnecessary interventions
High-flow nasal cannula (HFNC)2 L/kg/min (max ~20 L/min in infants); provides heated, humidified oxygen with low-level CPAP effect; decreases work of breathing; consider for moderate-severe bronchiolitis with persistent hypoxia or increased work of breathing
Hydration and feeding supportMaintain hydration via oral, NG, or IV route; small frequent feeds; IV maintenance fluids (isotonic) if oral intake insufficient
AntipyreticsAcetaminophen or ibuprofen (>6 months) for fever causing discomfort

The following interventions have been studied in multiple randomized controlled trials and are specifically not recommended for routine use in bronchiolitis.3 4

Intervention NOT RecommendedEvidence
Albuterol / salbutamolMultiple RCTs and meta-analyses show no improvement in disease severity, hospitalization rates, or duration of illness; may cause tachycardia and tremor
Epinephrine (nebulized)No sustained benefit in inpatient setting; may have marginal short-term effect in ED but does not reduce admission rate
Systemic corticosteroidsNo benefit demonstrated in multiple large RCTs; no reduction in admission, length of stay, or disease severity
Hypertonic saline (3%)Conflicting evidence; 2023 updated guideline notes insufficient evidence to recommend for ED use; may have modest benefit for inpatients (NNT ~6 for reducing LOS by 1 day) but not routinely recommended
AntibioticsNot indicated unless documented secondary bacterial infection (e.g., AOM, UTI, pneumonia)
Chest physiotherapyNo benefit; may worsen distress
Chest radiograph (routine)Not recommended for typical bronchiolitis; increases inappropriate antibiotic use; obtain only if diagnostic uncertainty or suspected complication
Viral testing (routine)Not required for management; may be useful for cohorting in hospitalized patients

2.4 Admission Criteria

CriterionDetails
Persistent hypoxiaSpO2 <90% despite nasal suctioning and supplemental oxygen
Significant respiratory distressModerate-severe retractions, tachypnea, nasal flaring, grunting
ApneaAny witnessed apneic episode
DehydrationUnable to maintain adequate oral intake
High-risk patientAge <12 weeks; premature birth (<37 weeks, especially <32 weeks); hemodynamically significant congenital heart disease; chronic lung disease; immunodeficiency; neuromuscular disease
Unreliable follow-upCaregiver unable to recognize worsening; no access to emergency care

2.5 Discharge Criteria

  • Maintaining SpO2 ≥90% on room air for ≥4 hours (including during sleep if inpatient)
  • Adequate oral intake (≥75% of usual volume)
  • Respiratory rate and work of breathing at or near baseline
  • Caregiver comfortable with suctioning and monitoring
  • Follow-up arranged within 24-48 hours3 4

3. Acute Asthma Exacerbation

Asthma is the most common chronic disease of childhood, affecting approximately 6-8% of children worldwide. Acute exacerbations are among the most frequent pediatric emergency department presentations. Rapid severity assessment and a stepwise escalation approach to bronchodilator, corticosteroid, and adjunctive therapy can prevent respiratory failure and reduce the need for mechanical ventilation.5 6

3.1 Acute Severity Classification

ParameterMildModerateSevereLife-Threatening
BreathlessnessWalking; can lie downTalking; prefers sittingAt rest; hunched forwardUnable to speak
Talks inSentencesPhrasesWordsCannot speak
AlertnessMay be agitatedUsually agitatedUsually agitatedDrowsy or confused
Respiratory rateIncreasedIncreasedOften >30/minParadoxical breathing
Accessory muscle useUsually notUsuallyUsuallyParadoxical thoracoabdominal movement
WheezeModerate, end-expiratoryLoud, throughout expirationLoud, throughout inspiration and expirationAbsent (“silent chest”)
Heart rate<100100–120>120Bradycardia
SpO2 (on room air)>95%90–95%<90%<90%
PEF (if obtainable)>70% predicted50–70% predicted<50% predicted<25% predicted
Pulsus paradoxusAbsent (<10 mmHg)May be present (10-25 mmHg)Often present (>25 mmHg)Absence suggests respiratory muscle fatigue

3.2 Stepwise Management of Acute Asthma

Step 1: All Severities — Initial Assessment and Treatment

InterventionDose / Details
Albuterol (salbutamol) nebulization0.15 mg/kg (min 2.5 mg, max 5 mg) every 20 minutes for 3 doses in the first hour; OR continuous nebulization 0.5 mg/kg/hr (max 15 mg/hr) for severe exacerbation
Albuterol MDI (mild-moderate)4-8 puffs via spacer every 20 min for up to 3 doses; each puff = 90 mcg
OxygenMaintain SpO2 ≥92-94%; use blow-by or nasal cannula as tolerated

Step 2: Moderate-Severe — Add Ipratropium and Systemic Steroids

InterventionDose / Details
Ipratropium bromide0.25 mg (<20 kg) or 0.5 mg (≥20 kg) nebulized with albuterol every 20 min for 3 doses in the first hour only; benefit limited to first 1-2 hours, not recommended after initial treatment
Systemic corticosteroidsDexamethasone 0.6 mg/kg PO/IM (max 16 mg) × 1-2 doses (evidence supports single dose non-inferiority to 5-day prednisone for most patients); OR Prednisone/Prednisolone 1-2 mg/kg/day PO (max 60 mg) for 3-5 days

Step 3: Severe — IV Access and Escalation

InterventionDose / Details
Continue continuous albuterol0.5 mg/kg/hr (max 15 mg/hr) via continuous nebulization
IV magnesium sulfate25-75 mg/kg IV (commonly 50 mg/kg; max 2 g) infused over 20-30 minutes; acts as smooth muscle relaxant; most effective when given early in severe exacerbation; monitor for hypotension
Reassess frequentlyIf not improving → proceed to Step 4

Step 4: Refractory/Life-Threatening — ICU-Level Interventions

InterventionDose / Details
IV terbutalineLoading dose: 10 mcg/kg IV over 10 minutes, then continuous infusion 0.1-10 mcg/kg/min; titrate to effect; monitor continuous ECG (risk of arrhythmia), lactate, potassium
IV aminophyllineLoading dose: 5-7 mg/kg IV over 30 minutes (omit if patient already on theophylline); maintenance: 0.5-1 mg/kg/hr continuous infusion; target serum level 10-15 mcg/mL; narrow therapeutic index — monitor for nausea, vomiting, seizures, arrhythmia
IV epinephrine0.01 mg/kg (1:10,000) IV/IO if near-arrest; or epinephrine drip 0.1-1 mcg/kg/min
Non-invasive ventilation (BiPAP)May reduce work of breathing and avoid intubation; settings: IPAP 10-16 cmH2O, EPAP 5-8 cmH2O; requires cooperative patient
Intubation (last resort)Ketamine 1-2 mg/kg IV for induction (bronchodilator properties); use largest ETT tolerated to reduce resistance; post-intubation: permissive hypercapnia strategy; low RR (8-12), long expiratory time (I:E 1:4-1:5), avoid air-trapping
Inhaled anestheticsSevoflurane or isoflurane via ventilator circuit in ICU — potent bronchodilators for truly refractory status asthmaticus

3.3 Disposition

ResponseDisposition
Good response — symptoms resolved, PEF >70%, SpO2 >94%, tolerating PODischarge with: albuterol MDI + spacer every 4-6 hrs; corticosteroid (dexamethasone or short course prednisone); written asthma action plan; follow-up in 1-5 days
Incomplete response — persistent symptoms, PEF 50-70%, requiring albuterol >q2hAdmit to floor; continue bronchodilators q1-2h; systemic steroids; reassess for ICU transfer if worsening
Poor response / life-threatening — severe symptoms, PEF <50%, altered consciousness, cyanosisAdmit to ICU; continuous nebulization; consider IV magnesium, terbutaline, aminophylline; prepare for possible intubation

4. Anaphylaxis

Anaphylaxis is a severe, potentially fatal systemic allergic reaction that occurs rapidly (usually within minutes to hours) after exposure to an allergen. In children, the most common triggers are foods (peanut, tree nuts, cow’s milk, egg, shellfish), insect stings, and medications. Rapid recognition and immediate intramuscular epinephrine administration are the cornerstones of treatment. Delays in epinephrine are associated with increased morbidity and mortality.7 8

4.1 Diagnostic Criteria

Anaphylaxis is highly likely when any ONE of the following criteria is met:

  1. Acute onset (minutes to hours) of skin/mucosal involvement (urticaria, flushing, angioedema) PLUS at least one of:

    • Respiratory compromise (dyspnea, wheeze, stridor, hypoxia)
    • Hypotension or end-organ dysfunction (collapse, syncope, incontinence)
  2. Two or more of the following occurring rapidly after exposure to a likely allergen:

    • Skin/mucosal involvement
    • Respiratory compromise
    • Hypotension or associated symptoms
    • Persistent GI symptoms (crampy abdominal pain, vomiting)
  3. Hypotension after exposure to a known allergen for that patient (age-specific: SBP <70 mmHg for 1 month-1 year, <70 + [2 × age] for 1-10 years, <90 mmHg for >10 years)

4.2 Treatment

PriorityInterventionDose / Details
1Epinephrine IM0.01 mg/kg of 1:1,000 (1 mg/mL) IM into anterolateral thigh; max 0.3 mg for children <30 kg; max 0.5 mg for children ≥30 kg; may repeat every 5-15 minutes as needed; this is the FIRST and MOST IMPORTANT treatment
2PositionSupine with legs elevated if hypotensive (Trendelenburg); if vomiting or dyspneic, allow position of comfort; do NOT sit or stand the patient up abruptly (risk of empty ventricle syndrome/sudden death)
3OxygenHigh-flow oxygen via non-rebreather mask (10-15 L/min)
4IV fluid bolus20 mL/kg NS IV bolus if hypotensive; repeat as needed (may require 40-60 mL/kg in severe anaphylactic shock)
5Albuterol2.5-5 mg nebulized for persistent bronchospasm not responsive to epinephrine
6H1 antihistamineDiphenhydramine 1 mg/kg IV/IM/PO (max 50 mg) — adjunct only, does NOT treat hypotension or airway obstruction
7H2 antihistamineRanitidine 1 mg/kg IV (max 50 mg) or famotidine 0.25 mg/kg IV (max 20 mg) — adjunct
8CorticosteroidsMethylprednisolone 1-2 mg/kg IV (max 125 mg) or dexamethasone 0.6 mg/kg (max 10 mg) — may help prevent biphasic reaction; onset too slow for acute treatment
9Glucagon (beta-blocker refractory)20-30 mcg/kg IV (max 1 mg) over 5 min; for patients on beta-blockers who fail to respond to epinephrine
10Epinephrine infusion (refractory shock)0.1-1 mcg/kg/min IV; titrate to blood pressure and heart rate

4.3 Observation Period

  • Observe for 4-6 hours minimum after resolution of symptoms to monitor for biphasic reactions (recurrence of symptoms without re-exposure, occurring in 1-20% of cases, typically within 1-72 hours)
  • Extended observation (12-24 hours) is recommended for:
    • Severe initial reaction (requiring multiple doses of epinephrine, hypotension, respiratory failure)
    • History of prior biphasic reaction
    • Previous severe anaphylaxis
    • Delayed presentation (>4 hours from exposure to treatment)
    • Poor access to emergency care

4.4 Discharge Requirements

  • Prescribe epinephrine auto-injector (0.15 mg for 7.5-25 kg; 0.3 mg for >25 kg) and demonstrate proper technique
  • Provide written anaphylaxis action plan
  • Instruct on allergen avoidance
  • Recommend medical alert identification
  • Refer to allergist/immunologist for formal allergy testing
  • Consider short course of oral corticosteroid (3-5 days) and antihistamine to reduce risk of biphasic reaction7 8

5. Foreign Body Aspiration

Foreign body aspiration (FBA) is a life-threatening emergency most common in children aged 1-3 years due to the oral phase of development, small airway caliber, and immature swallowing coordination. The most commonly aspirated objects include peanuts, other nuts and seeds, small food items (grapes, hot dogs, carrots), and small toy parts. Organic material causes more severe airway inflammation than inorganic objects.9 10

5.1 Clinical Presentation

Presentation PhaseFeatures
Acute choking eventSudden onset of coughing, gagging, stridor, or respiratory distress during eating or play; may witness the event
Asymptomatic intervalHours to days; initial cough subsides as foreign body lodges in one position; child may appear well
Complication phaseRecurrent or persistent cough, wheezing (often unilateral), recurrent pneumonia, fever, hemoptysis, lung abscess

5.2 BLS Management of Choking

Conscious Infant (<1 year) with Severe Airway Obstruction:

  1. 5 back blows: hold infant face-down along forearm, head lower than trunk, deliver 5 firm back blows between the scapulae with heel of hand
  2. 5 chest thrusts: turn infant face-up, deliver 5 chest thrusts (same location as CPR compressions) using 2 fingers
  3. Repeat back blows and chest thrusts until object is expelled or infant becomes unresponsive
  4. If unresponsive: begin CPR; each time the airway is opened for ventilation, look for the foreign body in the mouth — remove only if visualized; do NOT perform blind finger sweeps in infants/children

Conscious Child (>1 year) with Severe Airway Obstruction:

  1. Abdominal thrusts (Heimlich maneuver): stand behind child, place fist above umbilicus and below xiphoid, deliver quick inward-upward thrusts
  2. Repeat until object expelled or child becomes unresponsive
  3. If unresponsive: begin CPR as above

Mild Obstruction (Effective Cough):

  • Encourage coughing; do NOT interfere
  • Do NOT perform back blows or abdominal thrusts if the child is coughing effectively, speaking, or breathing
  • Monitor closely for deterioration to complete obstruction

5.3 Imaging

ModalityUtility
Chest radiograph (PA and lateral)First-line imaging; radio-opaque foreign bodies (metal, bone) are directly visible; most aspirated objects in children are radiolucent (food, plastic); indirect signs include unilateral hyperinflation, atelectasis, or mediastinal shift
Inspiratory/expiratory filmsExpiratory film may show air trapping distal to foreign body (hyperinflated hemithorax that fails to deflate); limited cooperation in young children
Bilateral decubitus filmsAlternative to expiratory film in young children; dependent lung should normally deflate — failure to deflate suggests ipsilateral air trapping
CT chestHigher sensitivity than plain film; consider if high clinical suspicion with negative radiographs
FluoroscopyReal-time assessment of diaphragm movement and mediastinal shift; rarely needed

5.4 Definitive Management

ScenarioManagement
Suspected FBA with stable airwayUrgent (not emergent) rigid bronchoscopy under general anesthesia — gold standard for diagnosis and removal
Confirmed FBA with respiratory distressEmergent bronchoscopy
Complete airway obstruction unresponsive to BLSEmergency cricothyrotomy or needle cricothyrotomy (rare in children); emergency bronchoscopy
Esophageal foreign bodyRigid esophagoscopy; button batteries in the esophagus require emergent removal (<2 hours) due to risk of caustic necrosis, perforation, and fistula formation

5.5 Key Points

  • Right mainstem bronchus is the most common site of lodging in older children and adults due to its more vertical orientation; in young children, either side may be affected with approximately equal frequency
  • Button battery ingestion is a true emergency if lodged in the esophagus — can cause full-thickness esophageal necrosis within 2 hours; honey (10 mL every 10 minutes) may be given en route if battery ingestion was <12 hours ago and child is >12 months old, as it has been shown to reduce tissue injury
  • Rigid bronchoscopy is preferred over flexible bronchoscopy for foreign body removal in children because it provides a secure airway, better visualization, and allows passage of larger instruments
  • A normal chest radiograph does not exclude foreign body aspiration — sensitivity is only 60-75%; maintain high clinical suspicion based on history9 10

6. Pediatric Upper Airway Emergencies: Differential Diagnosis

ConditionAgeOnsetFeverDroolingStridorCoughPositionKey Features
Croup6 mo–6 yrGradual (1-3 days)Low-gradeNoInspiratoryBarkyAnyWorse at night; steeple sign
Epiglottitis2–7 yr (unvaccinated); any ageRapid (hours)HighYesInspiratory (muffled)MinimalTripod, sniffingToxic appearance; thumb sign; rare since Hib vaccination
Bacterial tracheitis6 mo–8 yrDays (after viral URI)HighPossibleBiphasicProductiveAnyToxic, worsening after initial croup treatment; thick tracheal secretions
Peritonsillar abscess>5 yr, adolescentsDaysHighYesPossibleMuffledTrismus; uvular deviation; “hot potato” voice
Retropharyngeal abscess2–4 yrDaysHighYesPossibleNeck extensionNeck stiffness; widened prevertebral space on lateral neck XR (>7mm at C2, >14mm at C6)
Foreign body6 mo–4 yrSuddenNone (initially)PossibleVariableVariableWitnessed choking event; unilateral wheeze
AngioedemaAnyMinutes to hoursNonePossiblePossibleNoneLip/tongue/periorbital swelling; may be allergic or hereditary


  1. Bjornson CL, Johnson DW. “Croup in Children.” CMAJ. 2013;185(15):1317-1323. DOI: 10.1503/cmaj.121645 ↩︎ ↩︎ ↩︎

  2. Zoorob R, Sidani M, Murray J. “Croup: An Overview.” Am Fam Physician. 2011;83(9):1067-1073. URL: https://www.aafp.org/pubs/afp/issues/2011/0501/p1067.html ↩︎ ↩︎

  3. Ralston SL, Lieberthal AS, Meissner HC, et al. “Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis.” Pediatrics. 2014;134(5):e1474-e1502. DOI: 10.1542/peds.2014-2742 ↩︎ ↩︎ ↩︎

  4. Florin TA, Plint AC, Zorc JJ. “Viral Bronchiolitis.” Lancet. 2017;389(10065):211-224. DOI: 10.1016/S0140-6736(16)30951-5 ↩︎ ↩︎ ↩︎

  5. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2024. URL: https://ginasthma.org/gina-reports/ ↩︎

  6. Expert Panel Working Group of the National Heart, Lung, and Blood Institute. “2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.” J Allergy Clin Immunol. 2020;146(6):1217-1270. DOI: 10.1016/j.jaci.2020.10.003 ↩︎

  7. Shaker MS, Wallace DV, Golden DBK, et al. “Anaphylaxis — A 2020 Practice Parameter Update, Systematic Review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Analysis.” J Allergy Clin Immunol. 2020;145(4):1082-1123. DOI: 10.1016/j.jaci.2020.01.017 ↩︎ ↩︎

  8. Cardona V, Ansotegui IJ, Ebisawa M, et al. “World Allergy Organization Anaphylaxis Guidance 2020.” World Allergy Organ J. 2020;13(10):100472. DOI: 10.1016/j.waojou.2020.100472 ↩︎ ↩︎

  9. Fidkowski CW, Zheng H, Firth PG. “The Anesthetic Considerations of Tracheobronchial Foreign Bodies in Children: A Literature Review of 12,979 Cases.” Anesth Analg. 2010;111(4):1016-1025. DOI: 10.1213/ANE.0b013e3181ef3e9c ↩︎ ↩︎

  10. Committee on Injury, Violence, and Poison Prevention. “Prevention of Choking Among Children.” Pediatrics. 2010;125(3):601-607. DOI: 10.1542/peds.2009-2862 ↩︎ ↩︎